AI-driven diabetic retinopathy screening using ultra-widefield fundus images achieved a summary sensitivity of 85.0% and AUC of 0.870 in meta-analysis.
A systematic review and meta-analysis to February 9, 2025, evaluated artificial intelligence for diabetic retinopathy assessment using ultra-widefield color fundus images, which capture a larger retinal area without pupil dilation. Of 527 records, 17 studies were reviewed and four were meta-analyzed, all using Optos software, to estimate sensitivity and specificity for AI-driven screening.
- Impact 30%
- 69
- Evidence 25%
- 95
- Scale 20%
- 35
- Confidence 15%
- 87
- Recency 10%
- 85
Updated Jul 25, 2026 · TRV-2026-0564
ace